KraneShares Emerging Markets Healthcare Index ETF Price & Performance (KMED)

KraneShares has joined forces with InspereX to distribute its range of ETFs to independent broker-dealers and banks. This collaboration aims to broaden access to KraneShares’ innovative products, focusing on risk mitigation and market opportunities. Both firms expect the partnership to boost adoption among financial advisors nationwide.1

KMED, the KraneShares Emerging Markets Healthcare Index ETF, has struggled in recent years, posting a five-year annualized return of approximately -4.3%. Despite a strong 2021, the fund has faced headwinds, with healthcare sector concentration and fluctuating emerging market conditions weighing on performance.234

Rapid urbanization and rising incomes are projected to boost healthcare spending in emerging markets by over 24% of GDP by 2040. Government initiatives in countries like India and China are expected to further drive sector expansion, creating opportunities for companies in hospital management and biotechnology.4